全文获取类型
收费全文 | 2312篇 |
免费 | 107篇 |
国内免费 | 31篇 |
学科分类
医药卫生 | 2450篇 |
出版年
2024年 | 2篇 |
2023年 | 18篇 |
2022年 | 19篇 |
2021年 | 57篇 |
2020年 | 38篇 |
2019年 | 56篇 |
2018年 | 74篇 |
2017年 | 48篇 |
2016年 | 89篇 |
2015年 | 115篇 |
2014年 | 100篇 |
2013年 | 126篇 |
2012年 | 182篇 |
2011年 | 226篇 |
2010年 | 101篇 |
2009年 | 85篇 |
2008年 | 197篇 |
2007年 | 197篇 |
2006年 | 209篇 |
2005年 | 159篇 |
2004年 | 146篇 |
2003年 | 104篇 |
2002年 | 84篇 |
2001年 | 3篇 |
2000年 | 2篇 |
1999年 | 9篇 |
1998年 | 2篇 |
1996年 | 1篇 |
1994年 | 1篇 |
排序方式: 共有2450条查询结果,搜索用时 31 毫秒
21.
Equils O Deville JG Shapiro AM Sanchez CP 《Pediatric nephrology (Berlin, Germany)》1999,13(9):771-772
A 19-year-old female on chronic peritoneal dialysis developed acute peritonitis; multiple peritoneal fluid and catheter tip
cultures yielded Penicillium species. She promptly responded to catheter removal and intravenous amphotericin B, followed by oral fluconazole, without
further recurrences 1 year later. This is the first reported case of Penicillium peritonitis in the pediatric population. We review the microbiology and clinical spectrum of this disease, as well as the
few previous reported cases in adults.
Received: 2 November 1998 / Revised: 1 February 1999 / Accepted: 4 February 1999 相似文献
22.
23.
Mohammad Obaidul Hoque Ozlem Topaloglu Shahnaz Begum Rui Henrique Eli Rosenbaum Wim Van Criekinge William H Westra David Sidransky 《Journal of clinical oncology》2005,23(27):6569-6575
PURPOSE: Aberrant promoter hypermethylation of several known or putative tumor suppressor genes occurs frequently during the pathogenesis of prostate cancers and is a promising marker for cancer detection. We sought to develop a test for prostate cancer based on a quantitative methylation-specific polymerase chain reaction (QMSP) of multiple genes in urine sediment DNA. PATIENTS AND METHODS: We tested urine sediment DNA for aberrant methylation of nine gene promoters (p16INK4a, p14(ARF), MGMT, GSTP1, RARbeta2, CDH1 [E-cadherin], TIMP3, Rassf1A, and APC) from 52 patients with prostate cancer and 21 matched primary tumors by quantitative fluorogenic real-time polymerase chain reaction. We also analyzed urine sediments from 91 age-matched individuals without any history of genitourinary malignancy as controls. RESULTS: Promoter hypermethylation of at least one of the genes studied was detected in urine samples from all 52 prostate cancer patients. Urine samples from the 91 controls without evidence of genitourinary cancer revealed no methylation of the p16, ARF, MGMT, and GSTP1 gene promoters, whereas methylation of RARbeta2, TIMP3, CDH1, Rassf1A, and APC was detected at low levels. CONCLUSION: Overall, methylation found in urine samples matched the methylation status in the primary tumor. A combination of only four genes (p16, ARF, MGMT, and GSTP1) would theoretically allow us to detect 87% of prostate cancers with 100% specificity. Our data support further development of the noninvasive QMSP assay in urine DNA for early detection and surveillance of prostate cancer. 相似文献
24.
25.
26.
27.
28.
29.
30.
Berkdemir Siverekli N Sahin O Senel S Hayta E Kaptanoglu E Elden H 《Rheumatology international》2012,32(8):2453-2457
The aim of this study was to evaluate the bone mineral density (BMD) in familial Mediterranean fever (FMF) and to search the effects of genetic factors, family history of FMF and types of clinical attacks on BMD. Forty-four attack-free patients with FMF and 36 healthy voluntary subjects were included in the study. BMD measurements of lumbar spine and left proximal femur were performed by dual energy X-ray absorptiometry (DEXA). There was no statistically significant difference between patient and control groups regarding median values of lumbar BMD (P?=?0.06), lumbar T (P?=?0.08) and Z (P?=?0.12) scores, femoral neck BMD (P?=?0.13), femoral T (P?=?0.22) and Z (P?=?0.16) scores and total femur BMD (P?=?0.14), T (P?=?0.19) and Z (P?=?0.27) scores. Patients with negative FMF family history had significantly lower femoral neck BMD (P?=?0.018), femoral neck T (P?=?0.009) and Z (P?=?0.01) scores and total femur BMD (P?=?0.033) than patients with positive FMF family history. There was no significant difference among the groups regarding mutation characteristic and types of attacks in lumbar BMD, T and Z scores, femoral neck BMD, T and Z scores and total femur BMD, T and Z scores (P?>?0.05). We found that the bone loss of patients with FMF is not different from that of the controls. The increased bone loss in the patients with negative family history for FMF should be further investigated with larger patient groups taking into consideration of the risk factors related to family history for osteoporosis. 相似文献